InvestorsHub Logo

DewDiligence

12/09/10 4:57 PM

#110579 RE: masterlongevity #110577

DewDiligence

12/09/10 4:59 PM

#110580 RE: masterlongevity #110577

It’s amusing that Roche doesn’t think Laquinimod warrants inclusion in the chart.

genisi

12/10/10 5:46 AM

#110621 RE: masterlongevity #110577

it looks like they are going after PPMS as well as RRMS..

Well, it is PPMS plus Rituxan failed in this indication back in 2008.